CompletedNot Applicable

400mcg Sublingual Misoprostol as First Line Treatment

Senegal641 participantsStarted 2011-09

Plain-language summary

Women presenting with incomplete abortion and eligible for treatment with misoprostol were offered 400mcg sublingual misoprostol for treatment. Based on existing literature, the study hypothesises that women can successfully be treated with misoprostol alone as first line treatment.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * uterine size less than 12 weeks lmp * open cervical os * current or past vaginal bleeding * willing to provide contact information for follow-up * over 18 or with guardian consent Exclusion Criteria: * suspicion of ectopic pregnancy * intrauterine device in place * bad general health (infection, anemia, shoc)

What they're measuring

complete abortion

Timeframe: 1 year

Trial details

NCT IDNCT01939457

SponsorGynuity Health Projects

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-08

View on ClinicalTrials.gov More Incomplete Abortion trials